U.S. veterans’ study reveals key insights into Long COVID and protective role of vaccination

Study examines the clinical characteristics and trends of post-COVID-19 condition (PCC) in U.S. veterans, showing the protective effect of vaccination and the need for precise symptom documentation for effective research and clinical care.

UK taps Pfizer over hometown GSK to supply RSV vaccine doses

The UK government has selected Pfizer to supply millions of respiratory syncytial virus (RSV) vaccine doses, snubbing local pharma company GSK and its competing product

June 25, 2024

GSK acquires Aiolos Bio for $1.4bn to boost respiratory portfolio – Pharmaceutical Technology

Share this article GSK’s acquisition will give the company access to Aiolos’ AIO-001, a monoclonal antibody entering Phase II trials for the treatment of asthma

January 10, 2024

In a reality check for the field, AI underwhelms in Leash Bio’s binding contest: ‘No one did well’

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.